An Open-Label Phase 1 Study in Healthy Male Subjects to Investigate the Absorption, Metabolism and Excretion of [14C]-EP262 Following Single-Dose Oral Administration
Clinical trial NCT06645704 · COMPLETED
Trial details
- NCT number
- NCT06645704
- Sponsor
- Escient Pharmaceuticals, Inc
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-01
- Primary completion
- 2024-12-10
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.